COPD Prognosis in Covid Patients

Chronic Obstructive Pulmonary Disease Prognosis in Sars-covid 2 Infection

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05274490

Enrollment

100

Registered

2022-03-10

Start date

2021-06-01

Completion date

2022-01-01

Last updated

2022-03-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Respiratory Failure

Keywords

copd, prognosis, covid

Brief summary

In this prospective observational study, patients were selected from attendees of the intensive care unit. Different measures and outcomes had been studied and compared between patients with and without COPD, including hospitalization, medical costs, length of Intensive care stay, respiratory failure, and death rate.

Interventions

PROCEDUREintubation and mechanical ventilation

patients who were in need were intubated and mechanically ventilated

Study design

Observational model

CASE_CONTROL

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

20 Years to No maximum

Healthy volunteers

Inclusion criteria

* Age: more than 20 years old. * Both Males and females will be included. * COPD patients. * Recent confirmed the diagnosis with SARS-COV-2.

Exclusion criteria

* Pregnancy. * Malignancy. * Immunodeficiency disease

Design outcomes

Primary

Measure	Time frame	Description
SOFA score measurement in both groups	2 weeks	monitoring of SOFA items along two weeks

Secondary

Measure	Time frame	Description
prognosis of the disease	2 weeks	hospital stay, nedd for mechanical ventilation

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026